The superpotnent medication can cause major heath problems such as muscle weakness, hypertension, chest pain, rapid heart ...

Vitruvias Therapeutics has announced a voluntary recall of its thyroid tablets after tests indicated the potential for ...

More than 3600 bottles of Thyroid Tablets, USP 30 mg were recalled nationwide after lab tests showed the pills may be too strong.

Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg because testing found the medication may be ...

If you are pregnant and living with Graves' disease, your baby's thyroid function may also be affected. This is because the ...

A popular thyroid tablet medication has been recalled. Here's why and which product is affected.

Vitruvias Therapeutics has “ceased operations” after voluntarily recalling a batch recall of generic thyroid tablets due to ...

Vitruvias Therapeutics Inc. announced a voluntary recall of one lot (Lot No. 504950) of Thyroid Tablets, USP 30 mg, which was ...

Thyroid tablets distributed nationwide are being recalled over concerns that the product could be overly potent and ...

Vitruvias Therapeutics recalls 30 mg thyroid tablets nationwide over superpotency risks to elderly and pregnant patients.

Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, distributed nationwide after testing found the ...

The company said that the consumption of the “superpotent” tablets can cause an overactive thyroid.